Vivos Therapeutics, Inc.
VVOS • NASDAQ
Vivos Therapeutics, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO R. Kirk Huntsman, with a market cap of $13.7M.
Market Cap$13.7M
Employees114.0
CEOR. Kirk Huntsman
CountryUnited States of America
Healthcare
Medical - Devices
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
VVO
Vivos Therapeutics, Inc. FAQ
Common questions about Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $6.9M.
Vivos Therapeutics, Inc. has approximately 114 employees.